-
Ridinilazole (previously
known as SMT19969) is an
investigational small molecule antibiotic being evaluated for oral
administration to
treat Clostridioides...
- due to its non-superiority to
current therapies.
Cadazolid Fidaxomicin Ridinilazole SCHEMBL19952957 "Surotomycin Fact Sheet" (PDF). cubist.com. P Daley;...
- company's
leading shareholder and its CEO.
Summit is
focused on
developing ridinilazole, a
potential new
treatment for C. difficile.
Duggan is the
founder of...
- are
under development and
include rifalazil, tigecycline, ramoplanin,
ridinilazole, and SQ641.
Research has
studied whether the
appendix has any importance...
-
displaying little toxicity even in
regimes involving large doses.
Fidaxomicin Ridinilazole SCHEMBL19952957
Surotomycin Boschert S (19
September 2012). "Promising...
- of antibiotic-resistant
infections in humans.
Cadazolid Fidaxomicin Ridinilazole Surotomycin US 10662164,
Chang M,
Mobashery S,
Spink E, Ding D, Testero...
-
collaborators pla**** a key role in the
design of a
novel antibiotic,
ridinilazole,
which has
recently been ****essed in
phase III
clinical trials for the...
